Impact of CYP2C19 polymorphisms on serum concentration of voriconazole in iranian hematological patients
Impact of CYP2C19 polymorphisms on serum concentration of voriconazole in iranian hematological patients

Sholeh Ebrahimpour; Soha Namazi; Mehdi Mohammadi; Mohsen Nikbakht; Molouk Hadjibabaie; Hamidreza Taghvaye Masoumi; Ardeshir Ghavamzadeh

Volume 6, Issue 3 , July 2017, , Pages 151-157

Abstract
   This study aimed to determine the portion of Iranian patients who attain therapeutic serum concentrations of voriconazole (VRCZ) following administration of fixed doses. In addition, ...  Read More
Evaluation of the interaction of intravenous and oral voriconazole with oral cyclosporine in iranian HSCT patients
Evaluation of the interaction of intravenous and oral voriconazole with oral cyclosporine in iranian HSCT patients

Hamidreza Taghvaye Masoumi; Molouk Hadjibabaie; Mohammad Vaezi; Ardeshir Ghavamzadeh

Volume 6, Issue 2 , April 2017, , Pages 77-82

Abstract
  Voriconazole as a triazole antifungal agent is widely used for prophylaxis or treatment of fungal infections in allogeneic hematopoietic stem cell transplantation (HSCT). It can increase ...  Read More